Testosterone treatment impacts the intestinal microbiome of transgender individuals (Q29068)

From lgbtDB
Jump to navigation Jump to search
No description defined
  • Testosterone treatment impacts the intestinal microbiome of transgender individuals.
Language Label Description Also known as
English
Testosterone treatment impacts the intestinal microbiome of transgender individuals
No description defined
  • Testosterone treatment impacts the intestinal microbiome of transgender individuals.

Statements

Testosterone treatment impacts the intestinal microbiome of transgender individuals. (English)
1 reference
Medical modulation of sex hormone levels is a cornerstone of treatment for many conditions that impact well-being, including cancer, fertility/infertility, gender dysphoria, and chronic metabolic diseases such as diabetes and obesity. (English)
1 reference
The microbial residents of the intestine, known as the microbiota, interact with sex hormones in the intestine, and there is correlative evidence that this interaction is bidirectional. (English)
1 reference
Based on these published findings, we hypothesized that transgender individuals receiving exogenous testosterone as part of their gender-affirming medical treatment might undergo changes in their intestinal microbiome. (English)
1 reference
To test this, we collected 26 stool samples from nine individuals before and up to 8 months after initiation of treatment with exogenous testosterone and subjected these samples to metagenomic analysis. (English)
1 reference
While no species were significantly associated with the duration of testosterone therapy, pathways that generate glutamate increased in abundance, while those that consume glutamate decreased. (English)
1 reference
Glutamate is a precursor of arginine, and testosterone is known to increase levels of arginine and its metabolites in the plasma. (English)
1 reference
We hypothesize that testosterone increases the uptake of glutamate by enterocytes, thus decreasing access of the microbiota to this amino acid. (English)
1 reference
While this pilot study establishes the impact of testosterone therapy on the intestinal microbiome, a more comprehensive study is necessary to establish the impact of testosterone-driven metagenomic shifts on the stool metatranscriptome, the stool metabolome, and the plasma metabolome.IMPORTANCEThe human intestine is inhabited by a large community of microbes known as the microbiome. (English)
1 reference
Members of the microbiome consume the diet along with their human host. (English)
1 reference
Thus, the metabolomes of the host and microbe are intricately linked. (English)
1 reference
Testosterone alters the plasma metabolome. (English)
1 reference
In particular, plasma levels of arginine and its metabolites and testosterone are positively correlated. (English)
1 reference
To investigate the impact of exogenous testosterone on the microbiome, we analyzed the stool metagenomes of transgender individuals before and after the initiation of testosterone treatment. (English)
1 reference
In this pilot project, we found a modest impact on the microbiome community structure but an increase in the abundance of metabolic pathways that generate glutamate and spare glutamate consumption. (English)
1 reference
We propose that the host uses glutamate to generate arginine, decreasing the amount available for the microbiome. (English)
1 reference
29 October 2024
1 reference
29 October 2024
1 reference
9
1 reference
10
1 reference
e0055724
1 reference
e0055724
1 reference
The authors declare no conflict of interest. (English)
1 reference